People: Research!America Organization Elects Duke Chancellor Emeritus As Chairman

The board of directors of Research!America, a nonprofit organization whose focus is on educating the public about the benefits of biomedical research, has elected William G. Anlyan chairman. Anlyan, who since 1950 has been a Duke University professor of surgery and currently is a chancellor, emeritus, at Duke, assumed the lead position of Research!America's policy- making body on September 8. Anlyan says that, as the new chairman of the Alexandria-Va.-based organization--which has 165 instit

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Anlyan says that, as the new chairman of the Alexandria-Va.-based organization--which has 165 institutional members across the United States--"I see great potential to increase the public's understanding of the importance of biomedical research." Anlyan intends to pay particular attention to broadening the awareness of scientific research among young people in the United States.

The U.S., Anlyan says, is already the clear leader in biomedical research, but he believes the government should be funding more basic studies.

He notes that biomedical research has already led to great progress in medicine. In this regard, he says, "The beginning of September marked the 45th anniversary of the first day I became a third-year medical student at Yale. I put on a short white coat and stethoscope around my neck. At the university hospital, we had a whole wing that was filled with infectious diseases: one floor of tuberculosis, another floor of polio, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies